
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HUNK CRISPR/Cas9 KO Plasmid (h) | sc-405786 | 20 µg | $397.00 |
HUNK (hormonally upregulated Neu-associated kinase) encodes a serine/threonine protein kinase of the AMPK-related kinase family that integrates growth factor and hormone-responsive signaling with epithelial cell behavior. HUNK has been linked to regulation of cell survival programs, polarity maintenance, and vesicle/trafficking-associated processes that influence adhesion and migration, with reported connections to PI3K–AKT and MAPK network outputs in stress and proliferation contexts. Dysregulated HUNK expression or activity has been observed in multiple cancer-related models, where it is studied for roles in tumor cell adaptation, metastatic traits, and therapy response phenotypes. In addition, HUNK biology is relevant to kinase signaling cross-talk in breast and neural tissues, supporting mechanistic studies of pathway rewiring in disease-relevant cell states.
HUNK CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HUNK gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HUNK together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HUNK open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish HUNK protein expression.
This CRISPR knockout system enables efficient generation of HUNK-deficient cell models for investigation of HUNK signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.